News Releases

 
NYSE to Delist the Common Stock of American Oriental Bioengineering, Inc. and File Form 25 with Securities and Exchange Commission

NEW YORK, June 11, 2012 - NYSE Regulation, Inc. ("NYSE Regulation") announced today its final determination to remove the Common Stock of American Oriental Bioengineering, Inc. - ticker symbol AOB - from listing on the New York Stock Exchange and file a Form 25 Delisting Application to strike the Common Stock from listing with the Securities and Exchange Commission (the "Commission").
 
Pursuant to its rules, NYSE Regulation announced on May 25, 2012 the decision to delist the Common Stock and provided an opportunity for American Oriental Bioengineering, Inc. to appeal the decision to a Committee of the Board of Directors of NYSE Regulation.  The prescribed time for American Oriental Bioengineering, Inc. to file an appeal has expired.
 
The delisting will become effective ten days after the Form 25 is filed unless postponed by the Commission.
 
Company contact:
American Oriental Bioengineering, Inc. 
Hong Zhu 
(646) 367-1765 


See Section 802.00 of the NYSE Listed Company Manual for continued listing criteria and procedure for delisting